SAT0397 Safety and immunogenicity of 23-valent pneumococcal vaccine in sle patients
Sign Up to like & getrecommendations! Published in 2018 at "Annals of the Rheumatic Diseases"
DOI: 10.1136/annrheumdis-2018-eular.3663
Abstract: Background Immunisation with pneumococcal vaccine is the key prophylactic measure to protect patients with systemic lupus erythematosus (SLE) against severe respiratory infections. Objectives To study the efficacy and immunogenicity of 23-valent polysaccharide pneumococcal vaccine in… read more here.
Keywords: immunogenicity valent; sle; pneumococcal vaccine; vaccine ... See more keywords